My Cart [ 0 ]
Home > Chemicals > Inhibitors, Activators, Antagonists, and Agonists > A-Z Inhibitors, Activators, Antagonists, and Agonists > CNDAC (DFP-10917, TAS-109)

CNDAC (DFP-10917, TAS-109)

Catalog No. Product Name Size List Price (US$) Quantity
APIM050297 CNDAC (DFP-10917, TAS-109) 10 mg 150.00
APIM050297 CNDAC (DFP-10917, TAS-109) 50 mg 380.00
APIM050297 CNDAC (DFP-10917, TAS-109) 100 mg 580.00
Description

Background Information:

CNDAC (DFP-10917) is an orally available deoxycytosine nucleoside analog with potential antineoplastic activity. Upon administration, CNDAC (DFP-10917) is phosphorylated to generate its nucleotide form, functioning as a deoxycytosine mimic and is incorporated into DNA in tumor cells. This causes DNA strand breaks during polymerization due to beta-elimination during the fidelity checkpoint, resulting in G2/M phase-arrest and tumor cell apoptosis. It is currently under clinical evaluation to treat haematological malignancies.

APIM050297: CNDAC (DFP-10917, TAS-109)

CAS No.: 134665-72-8 (HCl salt) 135598-68-4 (free base).
Molecular Formula: C10H12N4O4?HCl.
Molecular Weight: 288.7.
Purity: 99.9% chem and optical purity.
QC: Achiral and Chiral HPLCs, 1H- and NOESY NMRs, Elemental Analysis Report.
Solubility: Refer to Certificate.
Storage: Refer to Certificate.

Related Links

See our Privacy Policy